Ftse Mib
34.127,62
-0,72%
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
NASDAQ
19.621,68
1,77%
Bitcoin
98.429,53
0,22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Invivyd Inc (IVVD) Invivyd Inc (IVVD) Notizie

Invivyd Inc

IVVD
0,58
0,10 (20,83%)
04 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/12/202422:13EDGAR2Form 8-K - Current report
02/12/202421:12EDGAR2Form 8-K - Current report
14/11/202415:16EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202413:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202413:19EDGAR2Form 8-K - Current report
14/11/202413:05GLOBEInvivyd Reports Third Quarter 2024 Financial Results and..
14/11/202413:01GLOBEInvivyd Announces New England Journal of Medicine Publishes..
12/11/202414:30GLOBEInvivyd Announces Preprints Conveying CANOPY Phase 3..
06/11/202414:01GLOBEInvivyd to Participate in the Guggenheim Securities..
06/11/202413:01GLOBEInvivyd to Host Third Quarter 2024 Financial Results and..
29/10/202412:17EDGAR2Form 8-K - Current report
29/10/202412:03GLOBEInvivyd Reports Preliminary Third Quarter 2024 Results,..
29/10/202412:01GLOBEInvivyd Phase 3 Long-Term Exploratory Clinical Efficacy Data..
16/10/202413:01GLOBEInvivyd to Present PEMGARDA™ (pemivibart) Data at Infectious..
01/10/202413:01GLOBEInvivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA..
23/9/202413:07EDGAR2Form 8-K - Current report
23/9/202413:01GLOBEInvivyd Provides Detailed Virology Data and Analysis of..
12/9/202413:01GLOBEInvivyd at the Ready for Upcoming Respiratory Virus Season..
06/9/202415:05EDGAR2Form 8-K - Current report
05/9/202413:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
04/9/202413:10EDGAR2Form 8-K - Current report
04/9/202413:01GLOBEInvivyd Doses First Participants in Phase 1 Clinical Trial..
03/9/202413:07EDGAR2Form 8-K - Current report
03/9/202413:01GLOBEInvivyd Announces Continued Neutralizing Activity of..
27/8/202414:05EDGAR2Form 8-K - Current report
27/8/202413:01GLOBEInvivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84%..
14/8/202414:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:20EDGAR2Form 8-K - Current report
14/8/202414:01GLOBEInvivyd Reports Second Quarter 2024 Financial Results and..
12/8/202422:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
01/7/202413:01GLOBEInvivyd Announces its Addition to the Russell 2000® and..
14/6/202413:07EDGAR2Form 8-K - Current report
14/6/202413:01GLOBEInvivyd Announces Antiviral Activity of VYD222 (pemivibart)..
06/6/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/6/202422:01GLOBEInvivyd to Participate at the Jefferies Global Healthcare..
31/5/202413:12EDGAR2Form 8-K - Current report
31/5/202413:05GLOBEInvivyd Announces General Alignment with U.S. FDA on a..
31/5/202413:00GLOBEInvivyd Announces the Appointment of Timothy Lee as Chief..
29/5/202413:00GLOBEInvivyd to Present Data at 2024 American Society of Clinical..
24/5/202400:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/5/202413:06EDGAR2Form 8-K - Current report
22/5/202413:00GLOBEInvivyd Elects Two New Independent Members to its Board of..
16/5/202422:11EDGAR2Form 144 - Report of proposed sale of securities
13/5/202422:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
09/5/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: 0,494 Min: 0,48 Max: 0,56
Chiusura: 0,48

La tua Cronologia

NASDAQ
IVVD
Invivyd
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network